Nasal Powder for Acute Migraine Gets FDA Nod
(MedPage Today) — The FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, Satsuma Pharmaceuticals announced Wednesday.
The product is the only DHE nasal powder for acute migraine…
